Global Biologics (Biosimilar) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product.
Based on the Biologics (Biosimilar) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Biologics (Biosimilar) market covered in Chapter 5:
Merck
Mylan
CP Guojian Pharmacy
Changchun High tech
Hospira
3sbio
Sanofi
Pfizer
Biotech Pharma
Sandoz
Teva
Gelgen Biopharma
AbbVie
Novo Nordisk
Novartis
Roche
Amgen
Johnson & Johnson
Lilly
In Chapter 6, on the basis of types, the Biologics (Biosimilar) market from 2015 to 2025 is primarily split into:
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
In Chapter 7, on the basis of applications, the Biologics (Biosimilar) market from 2015 to 2025 covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Based on the Biologics (Biosimilar) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Biologics (Biosimilar) market covered in Chapter 5:
Merck
Mylan
CP Guojian Pharmacy
Changchun High tech
Hospira
3sbio
Sanofi
Pfizer
Biotech Pharma
Sandoz
Teva
Gelgen Biopharma
AbbVie
Novo Nordisk
Novartis
Roche
Amgen
Johnson & Johnson
Lilly
In Chapter 6, on the basis of types, the Biologics (Biosimilar) market from 2015 to 2025 is primarily split into:
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
In Chapter 7, on the basis of applications, the Biologics (Biosimilar) market from 2015 to 2025 covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Biologics (Biosimilar) Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Merck
5.1.1 Merck Company Profile
5.1.2 Merck Business Overview
5.1.3 Merck Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Merck Biologics (Biosimilar) Products Introduction
5.2 Mylan
5.2.1 Mylan Company Profile
5.2.2 Mylan Business Overview
5.2.3 Mylan Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Mylan Biologics (Biosimilar) Products Introduction
5.3 CP Guojian Pharmacy
5.3.1 CP Guojian Pharmacy Company Profile
5.3.2 CP Guojian Pharmacy Business Overview
5.3.3 CP Guojian Pharmacy Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 CP Guojian Pharmacy Biologics (Biosimilar) Products Introduction
5.4 Changchun High tech
5.4.1 Changchun High tech Company Profile
5.4.2 Changchun High tech Business Overview
5.4.3 Changchun High tech Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Changchun High tech Biologics (Biosimilar) Products Introduction
5.5 Hospira
5.5.1 Hospira Company Profile
5.5.2 Hospira Business Overview
5.5.3 Hospira Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Hospira Biologics (Biosimilar) Products Introduction
5.6 3sbio
5.6.1 3sbio Company Profile
5.6.2 3sbio Business Overview
5.6.3 3sbio Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 3sbio Biologics (Biosimilar) Products Introduction
5.7 Sanofi
5.7.1 Sanofi Company Profile
5.7.2 Sanofi Business Overview
5.7.3 Sanofi Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sanofi Biologics (Biosimilar) Products Introduction
5.8 Pfizer
5.8.1 Pfizer Company Profile
5.8.2 Pfizer Business Overview
5.8.3 Pfizer Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Pfizer Biologics (Biosimilar) Products Introduction
5.9 Biotech Pharma
5.9.1 Biotech Pharma Company Profile
5.9.2 Biotech Pharma Business Overview
5.9.3 Biotech Pharma Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Biotech Pharma Biologics (Biosimilar) Products Introduction
5.10 Sandoz
5.10.1 Sandoz Company Profile
5.10.2 Sandoz Business Overview
5.10.3 Sandoz Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Sandoz Biologics (Biosimilar) Products Introduction
5.11 Teva
5.11.1 Teva Company Profile
5.11.2 Teva Business Overview
5.11.3 Teva Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Teva Biologics (Biosimilar) Products Introduction
5.12 Gelgen Biopharma
5.12.1 Gelgen Biopharma Company Profile
5.12.2 Gelgen Biopharma Business Overview
5.12.3 Gelgen Biopharma Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Gelgen Biopharma Biologics (Biosimilar) Products Introduction
5.13 AbbVie
5.13.1 AbbVie Company Profile
5.13.2 AbbVie Business Overview
5.13.3 AbbVie Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 AbbVie Biologics (Biosimilar) Products Introduction
5.14 Novo Nordisk
5.14.1 Novo Nordisk Company Profile
5.14.2 Novo Nordisk Business Overview
5.14.3 Novo Nordisk Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Novo Nordisk Biologics (Biosimilar) Products Introduction
5.15 Novartis
5.15.1 Novartis Company Profile
5.15.2 Novartis Business Overview
5.15.3 Novartis Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Novartis Biologics (Biosimilar) Products Introduction
5.16 Roche
5.16.1 Roche Company Profile
5.16.2 Roche Business Overview
5.16.3 Roche Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Roche Biologics (Biosimilar) Products Introduction
5.17 Amgen
5.17.1 Amgen Company Profile
5.17.2 Amgen Business Overview
5.17.3 Amgen Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Amgen Biologics (Biosimilar) Products Introduction
5.18 Johnson & Johnson
5.18.1 Johnson & Johnson Company Profile
5.18.2 Johnson & Johnson Business Overview
5.18.3 Johnson & Johnson Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Johnson & Johnson Biologics (Biosimilar) Products Introduction
5.19 Lilly
5.19.1 Lilly Company Profile
5.19.2 Lilly Business Overview
5.19.3 Lilly Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Lilly Biologics (Biosimilar) Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Biologics (Biosimilar) Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biologics (Biosimilar) Sales and Market Share by Types (2015-2020)
6.1.2 Global Biologics (Biosimilar) Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biologics (Biosimilar) Price by Types (2015-2020)
6.2 Global Biologics (Biosimilar) Market Forecast by Types (2020-2025)
6.2.1 Global Biologics (Biosimilar) Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biologics (Biosimilar) Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biologics (Biosimilar) Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biologics (Biosimilar) Sales, Price and Growth Rate of Recombinant Non-glycosylated Proteins
6.3.2 Global Biologics (Biosimilar) Sales, Price and Growth Rate of Recombinant Glycosylated Proteins
6.4 Global Biologics (Biosimilar) Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Recombinant Non-glycosylated Proteins Market Revenue and Sales Forecast (2020-2025)
6.4.2 Recombinant Glycosylated Proteins Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Biologics (Biosimilar) Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biologics (Biosimilar) Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biologics (Biosimilar) Revenue and Market Share by Applications (2015-2020)
7.2 Global Biologics (Biosimilar) Market Forecast by Applications (2020-2025)
7.2.1 Global Biologics (Biosimilar) Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biologics (Biosimilar) Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Oncology (2015-2020)
7.3.2 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Blood Disorders (2015-2020)
7.3.3 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Growth Hormonal Deficiency (2015-2020)
7.3.4 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Chronic and Autoimmune Disorders (2015-2020)
7.3.5 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Biologics (Biosimilar) Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Oncology Market Revenue and Sales Forecast (2020-2025)
7.4.2 Blood Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.3 Growth Hormonal Deficiency Market Revenue and Sales Forecast (2020-2025)
7.4.4 Chronic and Autoimmune Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.5 Others Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Biologics (Biosimilar) Sales by Regions (2015-2020)
8.2 Global Biologics (Biosimilar) Market Revenue by Regions (2015-2020)
8.3 Global Biologics (Biosimilar) Market Forecast by Regions (2020-2025)
9 NORTH AMERICA BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
9.3 North America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
9.4 North America Biologics (Biosimilar) Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biologics (Biosimilar) Market Analysis by Country
9.6.1 U.S. Biologics (Biosimilar) Sales and Growth Rate
9.6.2 Canada Biologics (Biosimilar) Sales and Growth Rate
9.6.3 Mexico Biologics (Biosimilar) Sales and Growth Rate
10 EUROPE BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
10.3 Europe Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biologics (Biosimilar) Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biologics (Biosimilar) Market Analysis by Country
10.6.1 Germany Biologics (Biosimilar) Sales and Growth Rate
10.6.2 United Kingdom Biologics (Biosimilar) Sales and Growth Rate
10.6.3 France Biologics (Biosimilar) Sales and Growth Rate
10.6.4 Italy Biologics (Biosimilar) Sales and Growth Rate
10.6.5 Spain Biologics (Biosimilar) Sales and Growth Rate
10.6.6 Russia Biologics (Biosimilar) Sales and Growth Rate
11 ASIA-PACIFIC BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biologics (Biosimilar) Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biologics (Biosimilar) Market Analysis by Country
11.6.1 China Biologics (Biosimilar) Sales and Growth Rate
11.6.2 Japan Biologics (Biosimilar) Sales and Growth Rate
11.6.3 South Korea Biologics (Biosimilar) Sales and Growth Rate
11.6.4 Australia Biologics (Biosimilar) Sales and Growth Rate
11.6.5 India Biologics (Biosimilar) Sales and Growth Rate
12 SOUTH AMERICA BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
12.3 South America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
12.4 South America Biologics (Biosimilar) Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biologics (Biosimilar) Market Analysis by Country
12.6.1 Brazil Biologics (Biosimilar) Sales and Growth Rate
12.6.2 Argentina Biologics (Biosimilar) Sales and Growth Rate
12.6.3 Columbia Biologics (Biosimilar) Sales and Growth Rate
13 MIDDLE EAST AND AFRICA BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biologics (Biosimilar) Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biologics (Biosimilar) Market Analysis by Country
13.6.1 UAE Biologics (Biosimilar) Sales and Growth Rate
13.6.2 Egypt Biologics (Biosimilar) Sales and Growth Rate
13.6.3 South Africa Biologics (Biosimilar) Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Biologics (Biosimilar) Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Merck
5.1.1 Merck Company Profile
5.1.2 Merck Business Overview
5.1.3 Merck Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Merck Biologics (Biosimilar) Products Introduction
5.2 Mylan
5.2.1 Mylan Company Profile
5.2.2 Mylan Business Overview
5.2.3 Mylan Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Mylan Biologics (Biosimilar) Products Introduction
5.3 CP Guojian Pharmacy
5.3.1 CP Guojian Pharmacy Company Profile
5.3.2 CP Guojian Pharmacy Business Overview
5.3.3 CP Guojian Pharmacy Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 CP Guojian Pharmacy Biologics (Biosimilar) Products Introduction
5.4 Changchun High tech
5.4.1 Changchun High tech Company Profile
5.4.2 Changchun High tech Business Overview
5.4.3 Changchun High tech Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Changchun High tech Biologics (Biosimilar) Products Introduction
5.5 Hospira
5.5.1 Hospira Company Profile
5.5.2 Hospira Business Overview
5.5.3 Hospira Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Hospira Biologics (Biosimilar) Products Introduction
5.6 3sbio
5.6.1 3sbio Company Profile
5.6.2 3sbio Business Overview
5.6.3 3sbio Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 3sbio Biologics (Biosimilar) Products Introduction
5.7 Sanofi
5.7.1 Sanofi Company Profile
5.7.2 Sanofi Business Overview
5.7.3 Sanofi Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sanofi Biologics (Biosimilar) Products Introduction
5.8 Pfizer
5.8.1 Pfizer Company Profile
5.8.2 Pfizer Business Overview
5.8.3 Pfizer Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Pfizer Biologics (Biosimilar) Products Introduction
5.9 Biotech Pharma
5.9.1 Biotech Pharma Company Profile
5.9.2 Biotech Pharma Business Overview
5.9.3 Biotech Pharma Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Biotech Pharma Biologics (Biosimilar) Products Introduction
5.10 Sandoz
5.10.1 Sandoz Company Profile
5.10.2 Sandoz Business Overview
5.10.3 Sandoz Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Sandoz Biologics (Biosimilar) Products Introduction
5.11 Teva
5.11.1 Teva Company Profile
5.11.2 Teva Business Overview
5.11.3 Teva Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Teva Biologics (Biosimilar) Products Introduction
5.12 Gelgen Biopharma
5.12.1 Gelgen Biopharma Company Profile
5.12.2 Gelgen Biopharma Business Overview
5.12.3 Gelgen Biopharma Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Gelgen Biopharma Biologics (Biosimilar) Products Introduction
5.13 AbbVie
5.13.1 AbbVie Company Profile
5.13.2 AbbVie Business Overview
5.13.3 AbbVie Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 AbbVie Biologics (Biosimilar) Products Introduction
5.14 Novo Nordisk
5.14.1 Novo Nordisk Company Profile
5.14.2 Novo Nordisk Business Overview
5.14.3 Novo Nordisk Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Novo Nordisk Biologics (Biosimilar) Products Introduction
5.15 Novartis
5.15.1 Novartis Company Profile
5.15.2 Novartis Business Overview
5.15.3 Novartis Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Novartis Biologics (Biosimilar) Products Introduction
5.16 Roche
5.16.1 Roche Company Profile
5.16.2 Roche Business Overview
5.16.3 Roche Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Roche Biologics (Biosimilar) Products Introduction
5.17 Amgen
5.17.1 Amgen Company Profile
5.17.2 Amgen Business Overview
5.17.3 Amgen Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Amgen Biologics (Biosimilar) Products Introduction
5.18 Johnson & Johnson
5.18.1 Johnson & Johnson Company Profile
5.18.2 Johnson & Johnson Business Overview
5.18.3 Johnson & Johnson Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Johnson & Johnson Biologics (Biosimilar) Products Introduction
5.19 Lilly
5.19.1 Lilly Company Profile
5.19.2 Lilly Business Overview
5.19.3 Lilly Biologics (Biosimilar) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Lilly Biologics (Biosimilar) Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Biologics (Biosimilar) Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biologics (Biosimilar) Sales and Market Share by Types (2015-2020)
6.1.2 Global Biologics (Biosimilar) Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biologics (Biosimilar) Price by Types (2015-2020)
6.2 Global Biologics (Biosimilar) Market Forecast by Types (2020-2025)
6.2.1 Global Biologics (Biosimilar) Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biologics (Biosimilar) Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biologics (Biosimilar) Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biologics (Biosimilar) Sales, Price and Growth Rate of Recombinant Non-glycosylated Proteins
6.3.2 Global Biologics (Biosimilar) Sales, Price and Growth Rate of Recombinant Glycosylated Proteins
6.4 Global Biologics (Biosimilar) Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Recombinant Non-glycosylated Proteins Market Revenue and Sales Forecast (2020-2025)
6.4.2 Recombinant Glycosylated Proteins Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Biologics (Biosimilar) Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biologics (Biosimilar) Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biologics (Biosimilar) Revenue and Market Share by Applications (2015-2020)
7.2 Global Biologics (Biosimilar) Market Forecast by Applications (2020-2025)
7.2.1 Global Biologics (Biosimilar) Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biologics (Biosimilar) Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Oncology (2015-2020)
7.3.2 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Blood Disorders (2015-2020)
7.3.3 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Growth Hormonal Deficiency (2015-2020)
7.3.4 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Chronic and Autoimmune Disorders (2015-2020)
7.3.5 Global Biologics (Biosimilar) Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Biologics (Biosimilar) Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Oncology Market Revenue and Sales Forecast (2020-2025)
7.4.2 Blood Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.3 Growth Hormonal Deficiency Market Revenue and Sales Forecast (2020-2025)
7.4.4 Chronic and Autoimmune Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.5 Others Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Biologics (Biosimilar) Sales by Regions (2015-2020)
8.2 Global Biologics (Biosimilar) Market Revenue by Regions (2015-2020)
8.3 Global Biologics (Biosimilar) Market Forecast by Regions (2020-2025)
9 NORTH AMERICA BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
9.3 North America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
9.4 North America Biologics (Biosimilar) Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biologics (Biosimilar) Market Analysis by Country
9.6.1 U.S. Biologics (Biosimilar) Sales and Growth Rate
9.6.2 Canada Biologics (Biosimilar) Sales and Growth Rate
9.6.3 Mexico Biologics (Biosimilar) Sales and Growth Rate
10 EUROPE BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
10.3 Europe Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biologics (Biosimilar) Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biologics (Biosimilar) Market Analysis by Country
10.6.1 Germany Biologics (Biosimilar) Sales and Growth Rate
10.6.2 United Kingdom Biologics (Biosimilar) Sales and Growth Rate
10.6.3 France Biologics (Biosimilar) Sales and Growth Rate
10.6.4 Italy Biologics (Biosimilar) Sales and Growth Rate
10.6.5 Spain Biologics (Biosimilar) Sales and Growth Rate
10.6.6 Russia Biologics (Biosimilar) Sales and Growth Rate
11 ASIA-PACIFIC BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biologics (Biosimilar) Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biologics (Biosimilar) Market Analysis by Country
11.6.1 China Biologics (Biosimilar) Sales and Growth Rate
11.6.2 Japan Biologics (Biosimilar) Sales and Growth Rate
11.6.3 South Korea Biologics (Biosimilar) Sales and Growth Rate
11.6.4 Australia Biologics (Biosimilar) Sales and Growth Rate
11.6.5 India Biologics (Biosimilar) Sales and Growth Rate
12 SOUTH AMERICA BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
12.3 South America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
12.4 South America Biologics (Biosimilar) Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biologics (Biosimilar) Market Analysis by Country
12.6.1 Brazil Biologics (Biosimilar) Sales and Growth Rate
12.6.2 Argentina Biologics (Biosimilar) Sales and Growth Rate
12.6.3 Columbia Biologics (Biosimilar) Sales and Growth Rate
13 MIDDLE EAST AND AFRICA BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biologics (Biosimilar) Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biologics (Biosimilar) Market Analysis by Country
13.6.1 UAE Biologics (Biosimilar) Sales and Growth Rate
13.6.2 Egypt Biologics (Biosimilar) Sales and Growth Rate
13.6.3 South Africa Biologics (Biosimilar) Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Biologics (Biosimilar) Market Size and Growth Rate 2015-2025
Table Biologics (Biosimilar) Key Market Segments
Figure Global Biologics (Biosimilar) Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biologics (Biosimilar) Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biologics (Biosimilar)
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Merck Company Profile
Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck Production and Growth Rate
Figure Merck Market Revenue ($) Market Share 2015-2020
Table Mylan Company Profile
Table Mylan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mylan Production and Growth Rate
Figure Mylan Market Revenue ($) Market Share 2015-2020
Table CP Guojian Pharmacy Company Profile
Table CP Guojian Pharmacy Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CP Guojian Pharmacy Production and Growth Rate
Figure CP Guojian Pharmacy Market Revenue ($) Market Share 2015-2020
Table Changchun High tech Company Profile
Table Changchun High tech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Changchun High tech Production and Growth Rate
Figure Changchun High tech Market Revenue ($) Market Share 2015-2020
Table Hospira Company Profile
Table Hospira Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hospira Production and Growth Rate
Figure Hospira Market Revenue ($) Market Share 2015-2020
Table 3sbio Company Profile
Table 3sbio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure 3sbio Production and Growth Rate
Figure 3sbio Market Revenue ($) Market Share 2015-2020
Table Sanofi Company Profile
Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi Production and Growth Rate
Figure Sanofi Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Biotech Pharma Company Profile
Table Biotech Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biotech Pharma Production and Growth Rate
Figure Biotech Pharma Market Revenue ($) Market Share 2015-2020
Table Sandoz Company Profile
Table Sandoz Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sandoz Production and Growth Rate
Figure Sandoz Market Revenue ($) Market Share 2015-2020
Table Teva Company Profile
Table Teva Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Production and Growth Rate
Figure Teva Market Revenue ($) Market Share 2015-2020
Table Gelgen Biopharma Company Profile
Table Gelgen Biopharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gelgen Biopharma Production and Growth Rate
Figure Gelgen Biopharma Market Revenue ($) Market Share 2015-2020
Table AbbVie Company Profile
Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie Production and Growth Rate
Figure AbbVie Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table Roche Company Profile
Table Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Production and Growth Rate
Figure Roche Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Lilly Company Profile
Table Lilly Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Lilly Production and Growth Rate
Figure Lilly Market Revenue ($) Market Share 2015-2020
Table Global Biologics (Biosimilar) Sales by Types (2015-2020)
Table Global Biologics (Biosimilar) Sales Share by Types (2015-2020)
Table Global Biologics (Biosimilar) Revenue ($) by Types (2015-2020)
Table Global Biologics (Biosimilar) Revenue Share by Types (2015-2020)
Table Global Biologics (Biosimilar) Price ($) by Types (2015-2020)
Table Global Biologics (Biosimilar) Market Forecast Sales by Types (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Sales Share by Types (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue Share by Types (2020-2025)
Figure Global Recombinant Non-glycosylated Proteins Sales and Growth Rate (2015-2020)
Figure Global Recombinant Non-glycosylated Proteins Price (2015-2020)
Figure Global Recombinant Glycosylated Proteins Sales and Growth Rate (2015-2020)
Figure Global Recombinant Glycosylated Proteins Price (2015-2020)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Recombinant Non-glycosylated Proteins (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Recombinant Non-glycosylated Proteins (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Recombinant Glycosylated Proteins (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Recombinant Glycosylated Proteins (2020-2025)
Table Global Biologics (Biosimilar) Sales by Applications (2015-2020)
Table Global Biologics (Biosimilar) Sales Share by Applications (2015-2020)
Table Global Biologics (Biosimilar) Revenue ($) by Applications (2015-2020)
Table Global Biologics (Biosimilar) Revenue Share by Applications (2015-2020)
Table Global Biologics (Biosimilar) Market Forecast Sales by Applications (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Sales Share by Applications (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Oncology Sales and Growth Rate (2015-2020)
Figure Global Oncology Price (2015-2020)
Figure Global Blood Disorders Sales and Growth Rate (2015-2020)
Figure Global Blood Disorders Price (2015-2020)
Figure Global Growth Hormonal Deficiency Sales and Growth Rate (2015-2020)
Figure Global Growth Hormonal Deficiency Price (2015-2020)
Figure Global Chronic and Autoimmune Disorders Sales and Growth Rate (2015-2020)
Figure Global Chronic and Autoimmune Disorders Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Oncology (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Others (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate (2015-2020)
Table Global Biologics (Biosimilar) Sales by Regions (2015-2020)
Table Global Biologics (Biosimilar) Sales Market Share by Regions (2015-2020)
Figure Global Biologics (Biosimilar) Sales Market Share by Regions in 2019
Figure Global Biologics (Biosimilar) Revenue and Growth Rate (2015-2020)
Table Global Biologics (Biosimilar) Revenue by Regions (2015-2020)
Table Global Biologics (Biosimilar) Revenue Market Share by Regions (2015-2020)
Figure Global Biologics (Biosimilar) Revenue Market Share by Regions in 2019
Table Global Biologics (Biosimilar) Market Forecast Sales by Regions (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Sales Share by Regions (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure North America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure North America Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure North America Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Canada Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Mexico Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure Europe Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure Europe Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure France Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Italy Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Spain Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Russia Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Japan Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South Korea Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Australia Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure India Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure South America Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure South America Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Argentina Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Columbia Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure UAE Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Egypt Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South Africa Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global Biologics (Biosimilar) Market Size and Growth Rate 2015-2025
Table Biologics (Biosimilar) Key Market Segments
Figure Global Biologics (Biosimilar) Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biologics (Biosimilar) Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biologics (Biosimilar)
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Merck Company Profile
Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck Production and Growth Rate
Figure Merck Market Revenue ($) Market Share 2015-2020
Table Mylan Company Profile
Table Mylan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mylan Production and Growth Rate
Figure Mylan Market Revenue ($) Market Share 2015-2020
Table CP Guojian Pharmacy Company Profile
Table CP Guojian Pharmacy Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CP Guojian Pharmacy Production and Growth Rate
Figure CP Guojian Pharmacy Market Revenue ($) Market Share 2015-2020
Table Changchun High tech Company Profile
Table Changchun High tech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Changchun High tech Production and Growth Rate
Figure Changchun High tech Market Revenue ($) Market Share 2015-2020
Table Hospira Company Profile
Table Hospira Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hospira Production and Growth Rate
Figure Hospira Market Revenue ($) Market Share 2015-2020
Table 3sbio Company Profile
Table 3sbio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure 3sbio Production and Growth Rate
Figure 3sbio Market Revenue ($) Market Share 2015-2020
Table Sanofi Company Profile
Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi Production and Growth Rate
Figure Sanofi Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Biotech Pharma Company Profile
Table Biotech Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biotech Pharma Production and Growth Rate
Figure Biotech Pharma Market Revenue ($) Market Share 2015-2020
Table Sandoz Company Profile
Table Sandoz Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sandoz Production and Growth Rate
Figure Sandoz Market Revenue ($) Market Share 2015-2020
Table Teva Company Profile
Table Teva Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Production and Growth Rate
Figure Teva Market Revenue ($) Market Share 2015-2020
Table Gelgen Biopharma Company Profile
Table Gelgen Biopharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gelgen Biopharma Production and Growth Rate
Figure Gelgen Biopharma Market Revenue ($) Market Share 2015-2020
Table AbbVie Company Profile
Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie Production and Growth Rate
Figure AbbVie Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table Roche Company Profile
Table Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Production and Growth Rate
Figure Roche Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Lilly Company Profile
Table Lilly Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Lilly Production and Growth Rate
Figure Lilly Market Revenue ($) Market Share 2015-2020
Table Global Biologics (Biosimilar) Sales by Types (2015-2020)
Table Global Biologics (Biosimilar) Sales Share by Types (2015-2020)
Table Global Biologics (Biosimilar) Revenue ($) by Types (2015-2020)
Table Global Biologics (Biosimilar) Revenue Share by Types (2015-2020)
Table Global Biologics (Biosimilar) Price ($) by Types (2015-2020)
Table Global Biologics (Biosimilar) Market Forecast Sales by Types (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Sales Share by Types (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue Share by Types (2020-2025)
Figure Global Recombinant Non-glycosylated Proteins Sales and Growth Rate (2015-2020)
Figure Global Recombinant Non-glycosylated Proteins Price (2015-2020)
Figure Global Recombinant Glycosylated Proteins Sales and Growth Rate (2015-2020)
Figure Global Recombinant Glycosylated Proteins Price (2015-2020)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Recombinant Non-glycosylated Proteins (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Recombinant Non-glycosylated Proteins (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Recombinant Glycosylated Proteins (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Recombinant Glycosylated Proteins (2020-2025)
Table Global Biologics (Biosimilar) Sales by Applications (2015-2020)
Table Global Biologics (Biosimilar) Sales Share by Applications (2015-2020)
Table Global Biologics (Biosimilar) Revenue ($) by Applications (2015-2020)
Table Global Biologics (Biosimilar) Revenue Share by Applications (2015-2020)
Table Global Biologics (Biosimilar) Market Forecast Sales by Applications (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Sales Share by Applications (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Oncology Sales and Growth Rate (2015-2020)
Figure Global Oncology Price (2015-2020)
Figure Global Blood Disorders Sales and Growth Rate (2015-2020)
Figure Global Blood Disorders Price (2015-2020)
Figure Global Growth Hormonal Deficiency Sales and Growth Rate (2015-2020)
Figure Global Growth Hormonal Deficiency Price (2015-2020)
Figure Global Chronic and Autoimmune Disorders Sales and Growth Rate (2015-2020)
Figure Global Chronic and Autoimmune Disorders Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Oncology (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Global Biologics (Biosimilar) Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate Forecast of Others (2020-2025)
Figure Global Biologics (Biosimilar) Sales and Growth Rate (2015-2020)
Table Global Biologics (Biosimilar) Sales by Regions (2015-2020)
Table Global Biologics (Biosimilar) Sales Market Share by Regions (2015-2020)
Figure Global Biologics (Biosimilar) Sales Market Share by Regions in 2019
Figure Global Biologics (Biosimilar) Revenue and Growth Rate (2015-2020)
Table Global Biologics (Biosimilar) Revenue by Regions (2015-2020)
Table Global Biologics (Biosimilar) Revenue Market Share by Regions (2015-2020)
Figure Global Biologics (Biosimilar) Revenue Market Share by Regions in 2019
Table Global Biologics (Biosimilar) Market Forecast Sales by Regions (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Sales Share by Regions (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biologics (Biosimilar) Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure North America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure North America Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure North America Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Canada Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Mexico Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure Europe Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure Europe Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure France Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Italy Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Spain Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Russia Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Japan Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South Korea Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Australia Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure India Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South America Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South America Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure South America Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure South America Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Argentina Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Columbia Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics (Biosimilar) Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics (Biosimilar) Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biologics (Biosimilar) Market Forecast Revenue ($) (2020-2025)
Figure UAE Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure Egypt Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
Figure South Africa Biologics (Biosimilar) Market Sales and Growth Rate (2015-2020)
